Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. cancer detection technologies
Show results for
Products
Services

Companies

News
Articles
Videos

Refine by
Date

  • Older

Cancer Detection Technologies Articles & Analysis

9 news found

GRAIL and Premier’s PINC AI™ Partner to Support Patient Access to Galleri® Multi-Cancer Early Detection Blood Test

GRAIL and Premier’s PINC AI™ Partner to Support Patient Access to Galleri® Multi-Cancer Early Detection Blood Test

’s PINC AI™, an advanced technology and services platform that provides artificial intelligence-enabled clinical performance improvement technologies, to support patient access to Galleri®, GRAIL’s groundbreaking multi-cancer early detection blood test. Under the partnership, Premier’s PINC AI will ...

ByGrail, Inc.


C2i Genomics Partners with OncoDNA to Bring AI-Powered Liquid Biopsy for Cancer Diagnostics Across Europe

C2i Genomics Partners with OncoDNA to Bring AI-Powered Liquid Biopsy for Cancer Diagnostics Across Europe

This partnership will also support a first-of-its-kind interventional clinical trial in France led by Gustave Roussy. As of 2021, the American Cancer Society reports that Europe accounts for 22.8% of the world’s total cancer cases and 19.6% of cancer deaths, but currently, there are few local genomic providers of cancer ...

ByOncoDNA S.A.


GRAIL Announces Partnership with Alignment Health Plan as First Medicare Advantage Plan to Offer Galleri® Multi-Cancer Early Detection Blood Test

GRAIL Announces Partnership with Alignment Health Plan as First Medicare Advantage Plan to Offer Galleri® Multi-Cancer Early Detection Blood Test

“Providing access to a technology that can detect cancer signals in the blood, even before symptoms appear, can help us decrease the burden of late-stage cancer diagnoses. ...

ByGrail, Inc.


Detecting the previously undetectable

Detecting the previously undetectable

That information helps surgeons identify previously undetectable cancer cells. This powerful cancer-cell detection method can be applied with minimal disruption to the surgical workflow. ...

ByReveal Surgical


Avelas Receives FDA Breakthrough Therapy Designation for Pegloprastide (AVB-620) for Use During Breast Cancer Surgery

Avelas Receives FDA Breakthrough Therapy Designation for Pegloprastide (AVB-620) for Use During Breast Cancer Surgery

Food and Drug Administration (FDA) for pegloprastide (AVB-620) for the intraoperative detection and visualization of positive margins during breast cancer surgery. ...

ByAvelas Biosciences


Illumina to Acquire GRAIL to Launch New Era of Cancer Detection

Illumina to Acquire GRAIL to Launch New Era of Cancer Detection

“We believe multi-cancer early detection technology could address a tremendous unmet need and reduce the cancer burden worldwide. ...

ByGrail, Inc.


Avelas Announces Top-Line Data Showing Pegloprastide (AVB-620) Can Significantly Improve Cancer Detection in Real-Time During Breast Cancer Surgery

Avelas Announces Top-Line Data Showing Pegloprastide (AVB-620) Can Significantly Improve Cancer Detection in Real-Time During Breast Cancer Surgery

” The primary endpoint of Period 2 of the pivotal study was the ability to detect cancer in margin-relevant tissue, using pegloprastide fluorescence imaging, in sufficient number of patients to demonstrate efficacy; this was achieved with high statistical significance (p-value < 0.001). The secondary endpoint of intraoperative patient-level ...

ByAvelas Biosciences


VisionGate is Leveraging the Cell-CT Platform to Expand Cancer Diagnostics Services, Biopharmaceutical Services and Cancer Prevention Medicines

VisionGate is Leveraging the Cell-CT Platform to Expand Cancer Diagnostics Services, Biopharmaceutical Services and Cancer Prevention Medicines

Nelson, PhD, Chairman and CEO in a statement. Cancer Diagnostics Services: Our initial cancer diagnostic services test, the LuCED® lung test, has been developed to support the early detection of lung cancer. ...

ByVisionGate, Inc


Guided Therapeutics and U.S. FDA Agree on Meeting Date to Plan Path Forward for LuViva Advanced Cervical Scan Premarket Approval Application

Guided Therapeutics and U.S. FDA Agree on Meeting Date to Plan Path Forward for LuViva Advanced Cervical Scan Premarket Approval Application

The LuViva is designed to detect cervical pre-cancer without taking a tissue sample and providing a result immediately, unlike any other women’s health cancer detection technology on the market. ...

ByGuided Therapeutics, Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT